Health system intelligence profile
Michigan Medicine / University of Michigan Medical School
Editorially verified · Last reviewed August 30, 2026
Intelligence summary
The official medical-school page presents the fund as part of Fast Forward Medical Innovation's pathway for advancing research-based biomedical opportunities toward commercialization.
Mandate and remit
The Michigan Biomedical Venture Fund is an early-stage investment program within Fast Forward Medical Innovation at the University of Michigan Medical School. It supports biomedical companies based on University of Michigan intellectual property and is positioned inside the medical school's commercialization pathway rather than as a general-purpose health-system corporate venture fund. The program evaluates opportunities arising from university research and supplies capital and commercialization support intended to move promising biomedical technologies toward company formation, external financing, and patient impact. Its official placement within Fast Forward Medical Innovation connects investment decisions with broader education, product-development, industry-partnership, and technology-transfer resources.
These routes appear in the program's sourced public record.
Fast Forward Medical Innovation ↗
University of Michigan Medical School commercialization unit that houses the fund and related biomedical innovation programs.
Fund or office: Michigan Biomedical Venture Fund
Early-stage investment in biomedical companies built around University of Michigan intellectual property and medical research.
The official medical-school page presents the fund as part of Fast Forward Medical Innovation's pathway for advancing research-based biomedical opportunities toward commercialization.
Use the program's published contact route for partnership, licensing, innovation, or program inquiries.
Comparable records based on shared public taxonomy, location, or commercialization route.
Same state · Same program type · Same commercialization route
Royal Oak, Michigan
Corewell Health Innovations Office
The Innovations Office is Corewell Health's commercialization arm, housed within the Corewell Health Research Institute in Southeast Michigan, that turns employee and researcher ideas into products, services or licenses.
Nonprofit
Read the intelligence briefReviewed August 30, 2026
Same state · Same program type · Same commercialization route
Grand Rapids, Michigan
Corewell Health Ventures (formerly Spectrum Health Ventures)
Corewell Health Ventures is the venture investment arm of Corewell Health, the integrated Michigan system created by the merger of Spectrum Health and Beaumont Health, which also owns the Priority Health plan.
Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Detroit, Michigan
Henry Ford Innovations
Henry Ford Innovations advances inventions developed by Henry Ford Health clinicians and researchers while also sourcing external technologies for the system.
Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Detroit, Michigan
Henry Ford + MSU Innovation Fund (Henry Ford Innovations)
Henry Ford Health and Michigan State University launched a joint Innovation Hub in 2025 anchored by a $10 million venture fund, the Henry Ford + MSU Innovation Fund, managed with the MSU Research Foundation.
Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Ann Arbor, Michigan
Fast Forward Medical Innovation
Michigan Medicine's Fast Forward Medical Innovation (FFMI) is an official biomedical commercialization and entrepreneurship program that describes itself as a front door to biomedical commercialization at the University of Michigan.
Academic
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Ann Arbor, Michigan
Coulter Translational Research Partnership Program
The U-M Coulter Translational Research Partnership funds collaborative projects that pair a biomedical engineering faculty member with a Michigan Medicine clinical faculty member to accelerate development and commercialization of medical devices, diagnostics and other biomedical products addressing unmet clinical needs.
Academic · Nonprofit
Read the intelligence briefReviewed August 30, 2026
Reviewed August 30, 2026. External source links open in a new tab.
Confidential comparison
Request a confidential conversation about the commercial opportunities, market pathways, and capabilities within your hospital's innovation portfolio. The public directory does not score or rank programs.